The medical device division of Johnson & Johnson unveiled its neurovascular business, Cerenovus, at the annual meeting of the Society of NeuroInterventional Surgery. The business, created from the company's recent acquisitions of brain aneurysm treatment device maker Pulsar Vascular and neurovascular therapy technology developer Neuravi, will concentrate on providing solutions for ischemic and hemorrhagic stroke.
J&J medical device division announces new neurovascular business
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.